                         SEQUENCE LISTING

<110>  Efroni, Sol
       Zilberberg, Alona
       Ben-Hamo, Rotem
 
<120>  POLYMORPHISM IN THE BCL2 GENE DETERMINES RESPONSE TO CHEMOTHERAPY

<130>  BEZ/001 PCT

<150>  62/014349
<151>  2014-06-19

<150>  62/120897
<151>  2015-02-26

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  720
<212>  DNA
<213>  Homo sapiens

<400>  1
atggcgcacg ctgggagaac agggtacgat aaccgggaga tagtgatgaa gtacatccat       60

tataagctgt cgcagagggg ctacgagtgg gatgcgggag atgtgggcgc cgcgcccccg      120

ggggccgccc ccgcaccggg catcttctcc tcccagcccg ggcacacgcc ccatccagcc      180

gcatcccggg acccggtcgc caggacctcg ccgctgcaga ccccggctgc ccccggcgcc      240

gccgcggggc ctgcgctcag cccggtgcca cctgtggtcc acctgaccct ccgccaggcc      300

ggcgacgact tctcccgccg ctaccgccgc gacttcgccg agatgtccag ccagctgcac      360

ctgacgccct tcaccgcgcg gggacgcttt gccacggtgg tggaggagct cttcagggac      420

ggggtgaact gggggaggat tgtggccttc tttgagttcg gtggggtcat gtgtgtggag      480

agcgtcaacc gggagatgtc gcccctggtg gacaacatcg ccctgtggat gactgagtac      540

ctgaaccggc acctgcacac ctggatccag gataacggag gctgggatgc ctttgtggaa      600

ctgtacggcc ccagcatgcg gcctctgttt gatttctcct ggctgtctct gaagactctg      660

ctcagtttgg ccctggtggg agcttgcatc accctgggtg cctatctggg ccacaagtga      720


<210>  2
<211>  22
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic oligo

<400>  2
tctgtctccg gtgaaggtga ag                                                22


<210>  3
<211>  21
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic olig

<400>  3
ggcatggcag acttgaaaaa g                                                 21


<210>  4
<211>  18
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic oligo

<400>  4
aggctgggat gcctttgt                                                     18


<210>  5
<211>  22
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic oligo

<400>  5
gacttcactt gtggcccaga ta                                                22


<210>  6
<211>  239
<212>  PRT
<213>  Homo sapiens

<400>  6

Met Ala His Ala Gly Arg Thr Gly Tyr Asp Asn Arg Glu Ile Val Met 
1               5                   10                  15      


Lys Tyr Ile His Tyr Lys Leu Ser Gln Arg Gly Tyr Glu Trp Asp Ala 
            20                  25                  30          


Gly Asp Val Gly Ala Ala Pro Pro Gly Ala Ala Pro Ala Pro Gly Ile 
        35                  40                  45              


Phe Ser Ser Gln Pro Gly His Thr Pro His Pro Ala Ala Ser Arg Asp 
    50                  55                  60                  


Pro Val Ala Arg Thr Ser Pro Leu Gln Thr Pro Ala Ala Pro Gly Ala 
65                  70                  75                  80  


Ala Ala Gly Pro Ala Leu Ser Pro Val Pro Pro Val Val His Leu Thr 
                85                  90                  95      


Leu Arg Gln Ala Gly Asp Asp Phe Ser Arg Arg Tyr Arg Arg Asp Phe 
            100                 105                 110         


Ala Glu Met Ser Ser Gln Leu His Leu Thr Pro Phe Thr Ala Arg Gly 
        115                 120                 125             


Arg Phe Ala Thr Val Val Glu Glu Leu Phe Arg Asp Gly Val Asn Trp 
    130                 135                 140                 


Gly Arg Ile Val Ala Phe Phe Glu Phe Gly Gly Val Met Cys Val Glu 
145                 150                 155                 160 


Ser Val Asn Arg Glu Met Ser Pro Leu Val Asp Asn Ile Ala Leu Trp 
                165                 170                 175     


Met Thr Glu Tyr Leu Asn Arg His Leu His Thr Trp Ile Gln Asp Asn 
            180                 185                 190         


Gly Gly Trp Asp Ala Phe Val Glu Leu Tyr Gly Pro Ser Met Arg Pro 
        195                 200                 205             


Leu Phe Asp Phe Ser Trp Leu Ser Leu Lys Thr Leu Leu Ser Leu Ala 
    210                 215                 220                 


Leu Val Gly Ala Cys Ile Thr Leu Gly Ala Tyr Leu Gly His Lys 
225                 230                 235                 


